Nanalysis Scientific (TSXV:NSCI) ROC % : -14.61% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Nanalysis Scientific's annualized return on capital (ROC %) for the quarter that ended in Mar. 2024 was -14.61%.

As of today (2024-06-09), Nanalysis Scientific's WACC % is 6.54%. Nanalysis Scientific's ROC % is -20.11% (calculated using TTM income statement data). Nanalysis Scientific earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Nanalysis Scientific ROC % Historical Data

The historical data trend for Nanalysis Scientific's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific ROC % Chart

Nanalysis Scientific Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROC %

Get a 7-Day Free Trial

0.68

-23.23

-5.83

-22.62

-24.87

Nanalysis Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROC %	Get a 7-Day Free Trial															-29.31	-23.21	-19.63	-30.48	-14.61

Nanalysis Scientific ROC % Calculation

Nanalysis Scientific's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

	ROC % (A: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Dec. 2022 )	+	Invested Capital (A: Dec. 2023 ))	/ count )
=	-13.514 * ( 1 - 0.07% )	/	( (60.618	+	47.984)	/ 2 )
=	-13.5045402	/	54.301
=	-24.87 %

where

	Invested Capital		(A: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	69.902	-	5.759	-	( 3.525	-	max(0, 13.506	-	21.955	+	3.525	))
=	60.618

	Invested Capital		(A: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	53.824	-	5.081	-	( 0.759	-	max(0, 14.596	-	17.914	+	0.759	))
=	47.984

Nanalysis Scientific's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-6.824 * ( 1 - -0.32% )	/	( (47.984	+	45.71)	/ 2 )
=	-6.8458368	/	46.847
=	-14.61 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	53.824	-	5.081	-	( 0.759	-	max(0, 14.596	-	17.914	+	0.759	))
=	47.984

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	53.979	-	6.575	-	( 1.694	-	max(0, 12.707	-	18.992	+	1.694	))
=	45.71

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

Nanalysis Scientific (TSXV:NSCI) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Nanalysis Scientific's WACC % is 6.54%. Nanalysis Scientific's ROC % is -20.11% (calculated using TTM income statement data). Nanalysis Scientific earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Nanalysis Scientific ROC % Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanalysis Scientific (TSXV:NSCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » ROC %

Comparable Companies

Traded in Other Exchanges

NSCIF:USA 1N1:Germany

Address

Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3

Website

https://www.nanalysis.com

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.

Executives

Michal Okoniewski

Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines